Copyright
©The Author(s) 2024.
World J Hepatol. Dec 27, 2024; 16(12): 1429-1440
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1429
Characteristic | Before PSM | After PSM | ||||
HBV carrier, n = 2128 | Healthy controls, n = 5666 | P value | HBV carrier, n = 2128 | Healthy controls, n = 2128 | P value | |
Age, year | 53.85 ± 9.68 | 51.29 ± 11.25 | < 0.001 | 53.85 ± 9.68 | 53.88 ± 9.71 | 0.926 |
Male | 775 (36.42) | 1553 (27.41) | < 0.001 | 775 (36.42) | 772 (36.28) | 0.924 |
BMI, kg/m2 | 24.16 ± 3.65 | 24.13 ± 3.88 | 0.778 | 24.16 ± 3.65 | 24.32 ± 3.80 | 0.151 |
Body fat % | 28.66 ± 7.67 | 29.52 ± 7.44 | < 0.001 | 28.66 ± 7.67 | 28.76 ± 7.62 | 0.670 |
WC, cm | 83.27 ± 10.29 | 82.82 ± 10.32 | 0.086 | 83.27 ± 10.29 | 83.83 ± 10.14 | 0.072 |
Metabolic parameters | ||||||
MASLD | 755 (35.48) | 2229 (39.34) | 0.002 | 755 (35.48) | 925 (43.47) | < 0.001 |
Diabetes | 204 (9.59) | 474 (8.37) | 0.088 | 204 (9.59) | 206 (9.68) | 0.917 |
Hypertension | 293 (13.77) | 724 (12.78) | 0.247 | 293 (13.77) | 330 (15.51) | 0.109 |
Hyperlipidemia | 182 (8.55) | 548 (9.67) | 0.131 | 182 (8.55) | 244 (11.47) | 0.002 |
Glucose, mg/dL | 96 (21.23) | 95 (19.00) | 0.036 | 96 (21.23) | 97 (21.66) | 0.325 |
HbA1c, % | 5.83 ± 0.83 | 5.80 ± 0.75 | 0.110 | 5.83 ± 0.83 | 5.86 ± 0.84 | 0.205 |
TG, mg/dL | 107.73 ± 73.91 | 115.42 ± 77.93 | < 0.001 | 107.73 ± 73.91 | 121.34 ± 80.35 | < 0.001 |
CHO, mg/dL | 194.28 ± 35.76 | 197.94 ± 36.28 | < 0.001 | 194.28 ± 35.76 | 198.76 ± 35.46 | < 0.001 |
HDL, mg/dL | 55.23 ± 13.62 | 55.89 ± 13.74 | 0.059 | 55.23 ± 13.62 | 54.74 ± 13.70 | 0.242 |
LDL, mg/dL | 118.93 ± 31.26 | 121.78 ± 32.15 | < 0.001 | 118.93 ± 31.26 | 122.86 ± 31.63 | < 0.001 |
Liver parameters | ||||||
AST, U/L | 27.97 ± 15.57 | 24.35 ± 12.12 | < 0.001 | 27.97 ± 15.57 | 24.71 ± 10.15 | < 0.001 |
ALT, U/L | 28.57 ± 29.68 | 23.10 ± 22.66 | < 0.001 | 28.57 ± 29.68 | 23.63 ± 17.79 | < 0.001 |
GGT, U/L | 20.03 ± 19.47 | 22.21 ± 20.17 | < 0.001 | 20.03 ± 19.47 | 23.47 ± 22.09 | < 0.001 |
Fatty liver index | 23.12 ± 21.76 | 24.85 ± 24.05 | 0.004 | 23.12 ± 21.76 | 26.89 ± 24.28 | < 0.001 |
FIB-4 | 1.49 ± 0.75 | 1.23 ± 0.61 | < 0.001 | 1.49 ± 0.75 | 1.31 ± 0.59 | < 0.001 |
FIB-4 > 2 | 407 (19.13) | 578 (10.20) | < 0.0001 | 407 (19.13) | 260 (12.22) | < 0.0001 |
Other parameter | ||||||
Carotid plaque | 533 (25.05) | 1266 (22.34) | 0.012 | 533 (25.05) | 566 (26.60) | 0.248 |
- Citation: Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, Kao JH. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol 2024; 16(12): 1429-1440
- URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1429.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1429